Jaguar Health Hauptforum Forum: Community User: MaLiMo

https://jaguarhealth.gcs-web.com/node/15551/html

They announced that the maturity date of some convertible promissory notes (≥ US$2.57 million) from their March 2025 bridge financing has been extended from 30 June 2025 to 30 January 2026. jaguarhealth.gcs-web.com • The extension provides short-term financial flexibility and avoids an immediate liquidity crunch. • While not a "business triumph", it is a positive step in managing financial risk. 3. They received notice of a US$250,000 grant from the U.S. Food and Drug Administration (FDA) to fund a confirmatory trial to support approval of their veterinary product (Canalevia® for dogs with chemotherapy-induced diarrhea).

Das sagt Chat GPT Positive developments 1. The company announced proof-of-concept results for its drug crofelemer in pediatric intestinal failure patients: it reduced the need for total parenteral nutrition (TPN) by up to ~27% in one microvillus-inclusion-disease (MVID) patient and ~12.5 % in an SBS-IF (short bowel syndrome with intestinal failure) patient. GuruFocus +1 • This is a meaningful result given the seriousness of these orphan conditions. • It supports the company's rare-disease development strategy. • The company says 2025 is a "year of catalysts" for crofelemer in both rare-disease intestinal failure and cancer therapy-related diarrhea.

https://jaguarhealth.gcs-web.com/news-releases/news-release-details/jaguar-health-announces-new-employee-inducement-grants-under-13

Naja, irgendwann muss ja mal wieder was veröffentlicht werden und manch andere investierte haben eventuell mehr Infos

Hab hier noch nie welche gelesen . Du siehst doch bei Kennzahlen,es gibt hier keine...🤷

Hallo, kann mir jemand sagen, wann hier die nächsten Quartalszahlen veröffentlicht werden?

https://jaguarhealth.gcs-web.com/node/15531/html

https://jaguarhealth.gcs-web.com/node/15526/html

https://jaguarhealth.gcs-web.com/node/15521/html

https://jaguarhealth.gcs-web.com/news-releases/news-release-details/fda-authorized-expanded-access-programs-utilizing-jaguar-healths

https://jaguarhealth.gcs-web.com/news-releases/news-release-details/jaguar-health-receives-notice-250000-fda-grant-fund-confirmatory

https://jaguarhealth.gcs-web.com/news-releases/news-release-details/jaguar-health-submits-orphan-drug-designation-application-fda

https://jaguarhealth.gcs-web.com/news-releases/news-release-details/jaguar-health-presenting-september-25-emerging-growth-conference